NEW YORK, Sept. 30, 2016 /PRNewswire/ -- Rosen Law
Firm, a global investor rights law firm, reminds purchasers of
Spectrum Pharmaceuticals, Inc. securities (NASDAQ: SPPI) from
December 16, 2015 through
September 16, 2016, both dates
inclusive (the "Class Period") of the important November 21, 2016 lead plaintiff deadline in the
class action filed by the firm.
To join the Spectrum class action, go to the website at
http://www.rosenlegal.com/cases-955.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or
email pkim@rosenlegal.com or kchan@rosenlegal.com for information
on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR
CHOICE.
According to the lawsuit, throughout the Class Period defendants
made false and/or misleading statements and/or failed to disclose
that: (1) the FDA previously questioned whether the data from the
611 and 612 Studies were clinically meaningful; (2) the FDA advised
defendants in December 2012 not to
submit the New Drug Application based on data from the 611 and 612
Studies; and (3) as a result, defendants' public statements about
Spectrum's business, operations and prospects were materially false
and misleading at all relevant times. When the true details entered
the market, the lawsuit claims that investors suffered damages.
Attorney Advertising. Prior results do not guarantee a
similar outcome.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
November 21, 2016. If you wish to
join the litigation, go to http://www.rosenlegal.com/cases-955.html
or to discuss your rights or interests regarding this class action,
please contact Phillip Kim or
Kevin Chan of Rosen Law Firm toll
free at 866-767-3653 or via email at pkim@rosenlegal.com or
kchan@rosenlegal.com.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
Logo - http://photos.prnewswire.com/prnh/20160907/405060LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/securities-notice-rosen-law-firm-reminds-spectrum-pharmaceuticals-inc-investors-of-important-deadline-in-class-action-filed-by-firm--sppi-300337309.html
SOURCE Rosen Law Firm, P.A.